India Globalization Capital Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IGC | ZTS | TAK | GRFS | NBIX |
| Company | India Globalization Capital Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Grifols S.A. ADR | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.4375 | 150.97 | 13.15 | 6.33 | 139.37 |
| High | 0.4479 | 153.59 | 13.19 | 6.37 | 139.37 |
| Low | 0.4170 | 150.04 | 13.07 | 6.12 | 136.06 |
| Last | 0.4340 | 153.29 | 13.11 | 6.27 | 136.47 |
| Change | -0.0050 | +2.41 | -0.12 | -0.12 | -2.50 |
| % Change | -1.14% | +1.60% | -0.91% | -1.88% | -1.80% |
| Volume | 208,628 | 3,015,607 | 1,020,052 | 876,827 | 372,071 |
| 20-Day Average Volume | 1,690,010 | 4,106,363 | 1,727,471 | 1,353,784 | 773,505 |
| Previous Close | 0.4390 | 150.88 | 13.23 | 6.39 | 138.97 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5164 | 157.89 | 13.43 | 6.69 | 136.49 |
| 20-Day Raw Stochastic | 6.13% | 31.45% | 3.37% | 13.11% | 42.20% |
| 20-Day Relative Strength | 48.29% | 37.33% | 34.36% | 42.72% | 50.00% |
| Weighted Alpha | +2.60 | -18.45 | -21.74 | -4.43 | +36.17 |
| Today's Opinion | 88% Buy | 88% Sell | 100% Sell | 100% Sell | 64% Buy |
| Previous Opinion | 88% Buy | 88% Sell | 100% Sell | 100% Sell | 96% Buy |
| Last Month's Opinion | 56% Buy | 40% Sell | 56% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.15% since 04/18/24 | -0.02% since 04/18/24 | -0.46% since 04/18/24 | -3.82% since 04/18/24 | +2.92% since 04/18/24 |
| Low | 0.4130 on 04/24/24 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 6.13 on 04/25/24 | 130.13 on 04/19/24 |
| High | 0.5080 on 04/22/24 | 153.59 on 04/25/24 | 13.41 on 04/23/24 | 6.66 on 04/23/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | +5.75% since 03/25/24 | -8.77% since 03/25/24 | -7.42% since 03/25/24 | -1.10% since 03/25/24 | -2.74% since 03/25/24 |
| Low | 0.3530 on 03/26/24 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 6.13 on 04/25/24 | 130.13 on 04/19/24 |
| High | 0.9099 on 04/04/24 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 7.35 on 04/09/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | +51.89% since 01/25/24 | -18.28% since 01/25/24 | -10.46% since 01/25/24 | -17.56% since 01/25/24 | -3.27% since 01/25/24 |
| Low | 0.2700 on 02/22/24 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 5.30 on 03/06/24 | 128.00 on 02/07/24 |
| High | 0.9099 on 04/04/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 9.37 on 02/28/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +44.37% since 10/25/23 | -6.47% since 10/25/23 | -9.66% since 10/25/23 | -18.94% since 10/25/23 | +26.03% since 10/25/23 |
| Low | 0.2501 on 12/20/23 | 144.80 on 04/22/24 | 13.07 on 04/25/24 | 5.30 on 03/06/24 | 103.63 on 11/10/23 |
| High | 0.9099 on 04/04/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 12.15 on 12/29/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 29,331 | 69,006,328 | 41,870,544 | 4,393,509 | 13,828,489 |
| Shares Outstanding, K | 66,813 | 457,359 | 3,164,818 | 687,560 | 99,507 |
| Annual Sales | 910,000 | 8,544,000,000 | 29,803,340,000 | 7,134,500,000 | 1,887,100,000 |
| Annual Net Income | -11,510,000 | 2,344,000,000 | 2,345,930,000 | 131,340,000 | 249,700,000 |
| Last Quarter Sales | 200,000 | 2,213,000,000 | 7,556,070,000 | 2,025,030,000 | 515,200,000 |
| Last Quarter Net Income | -5,590,000 | 525,000,000 | 718,900,000 | 125,920,000 | 147,700,000 |
| 60-Month Beta | 1.71 | 0.85 | 0.53 | 0.56 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 02/14/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 0.09 on 07/27/23 | 1.44 on 02/07/24 |
| Latest Earnings Date | 02/13/24 | 05/02/24 | 05/09/24 | 03/05/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | 0.370 on 06/03/21 | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | 06/03/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.11 | 6.86 | 0.00 | 57.89 |